Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2022-12-24 2022-12-23
Drug Identification Number 02444739 02444739
Brand name ZOLEDRONIC ACID FOR INJECTION ZOLEDRONIC ACID FOR INJECTION
Common or Proper name ZOLEDRONIC ACID FOR INJECTION ZOLEDRONIC ACID FOR INJECTION
Company Name JUNO PHARMACEUTICALS CORP. JUNO PHARMACEUTICALS CORP.
Ingredients ZOLEDRONIC ACID ZOLEDRONIC ACID
Strength(s) 4MG 4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 5 mL vial 5 mL vial
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-12-23 2022-12-23
Actual discontinuation date 2022-12-23 2022-12-23
Remaining supply date 2022-12-23 2022-12-23
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments